| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Laboratory of Molecular Endocrinology, Laval University Medical Research Center and Laval University, Ste-Foy, Québec, Canada G1V 4G2
Address all correspondence and requests for reprints to: Dr. Claude Labrie, Laboratory of Molecular Endocrinology, Laval University Medical Research Center, 2705 Laurier Boulevard, Ste-Foy, Québec, Canada G1V 4G2. E-mail: claude.labrie{at}crchul.ulaval.ca
Androgens inhibit the growth of breast cancer cells, but the mechanism of androgen-induced growth inhibition has not yet been elucidated, and few androgen-responsive genes have been identified. We, therefore, used differential display PCR to identify novel androgen-responsive genes in ZR-751 human breast cancer cells. The human UDP-glucose dehydrogenase gene (UDPGDH), which was not known to be androgen regulated, was detected and cloned by complementary DNA library screening. The UDPGDH open reading frame codes for a protein of 494 amino acids that migrates at an apparent molecular mass of approximately 54 kDa. Northern blot analysis revealed the existence of two messenger RNA species of approximately 3.5 and 2.7 kb in all of the human breast cancer cell lines examined. The major UDPGDH transcript was induced rapidly (within 6 h) by dihydrotestosterone in ZR-751 cells, and a maximal 13-fold induction was observed after 24 h of treatment. The increase in UDPGDH messenger RNA was completely prevented by coincubation with the pure antiandrogen hydroxyflutamide, but not by cycloheximide, indicating that UDPGDH is directly regulated by the androgen receptor. As UDPGDH is required for the production of uridine 5'-diphosphoglucuronic acid, a substrate for the steroid-conjugating uridine diphospho-glucuronosyltransferase enzymes, up-regulation of UDPGDH expression by androgens might play an important role in the control of sex steroid inactivation via glucuronidation in breast cancer cells.
This article has been cited by other articles:
![]() |
Q. Wei, R. Galbenus, A. Raza, R. L. Cerny, and M. A. Simpson Androgen-Stimulated UDP-Glucose Dehydrogenase Expression Limits Prostate Androgen Availability without Impacting Hyaluronan Levels Cancer Res., March 15, 2009; 69(6): 2332 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Huh, H.-Y. Yoon, H.-J. Lee, W.-B. Choi, S.-J. Yang, and S.-W. Cho Importance of Gly-13 for the Coenzyme Binding of Human UDP-glucose Dehydrogenase J. Biol. Chem., September 3, 2004; 279(36): 37491 - 37498. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Sommer, J. J. Barycki, and M. A. Simpson Characterization of Human UDP-glucose Dehydrogenase: CYS-276 IS REQUIRED FOR THE SECOND OF TWO SUCCESSIVE OXIDATIONS J. Biol. Chem., May 28, 2004; 279(22): 23590 - 23596. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bontemps, B. Vuillermoz, F. Antonicelli, C. Perreau, J.-L. Danan, F.-X. Maquart, and Y. Wegrowski Specific Protein-1 Is a Universal Regulator of UDP-glucose Dehydrogenase Expression: ITS POSITIVE INVOLVEMENT IN TRANSFORMING GROWTH FACTOR-{beta} SIGNALING AND INHIBITION IN HYPOXIA J. Biol. Chem., June 6, 2003; 278(24): 21566 - 21575. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lapointe and C. Labrie Role of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation Endocrinology, October 1, 2001; 142(10): 4331 - 4338. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |